Dexanabinol

DRUG4 trials

Sponsors

Pharmos, e-Therapeutics PLC, Santosh Kesari, M.D., Ph.D.

Conditions

Brain CancerHepatocellular CarcinomaPancreatic CancerSolid TumourTraumatic Brain Injury

Phase 1

A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours

CompletedNCT01489826

e-Therapeutics PLCSolid Tumour

Start: 2012-01-31End: 2015-07-31Updated: 2017-02-09

Dexanabinol in Patients With Brain Cancer

CompletedNCT01654497

Santosh Kesari, M.D., Ph.D.Brain Cancer

Start: 2012-06-30End: 2017-07-31Updated: 2019-11-14

A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours

e-Therapeutics PLCHepatocellular Carcinoma, Pancreatic Cancer

Start: 2015-04-30End: 2016-12-31Target: 112Updated: 2016-04-06

Phase 3

Dexanabinol in Severe Traumatic Brain Injury

CompletedNCT00129857

PharmosTraumatic Brain Injury

Start: 2001-01-31End: 2004-09-30Target: 860Updated: 2006-05-05

Related Papers

Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial.

2006-01-01207 citations